期刊文献+

miR-21抑制剂在5-FU抑制肠癌细胞增殖中的作用 被引量:8

Study on the role of miR-21 inhibitor in 5-FU inhibiting the proliferation of intestinal carcinoma cells
暂未订购
导出
摘要 目的观察miR-21抑制剂在5-氟尿嘧啶(5-FU)抑制肠癌细胞增殖中的作用,并探讨其分子机制。方法采用qRTPCR技术检测肠癌组织中miR-21的表达;应用CCK-8试剂盒检测肠癌细胞的增殖活力;运用Western blot法检测细胞中PTEN和AKT的磷酸化表达水平。结果肠癌组织中,miR-21的表达高于正常大肠组织;利用miR-21抑制剂联合5-FU处理肠癌细胞HT-29和LoVo,细胞增殖活力显著低于单独使用5-FU处理组(P<0.001);Western blot检测结果表明:miR-21抑制剂联合5-FU处理细胞后,抑癌基因PTEN的表达水平升高,AKT的磷酸化水平降低。结论 miR-21抑制剂可显著增强肠癌细胞对5-FU的敏感性。 Purpose To investigate the suppression of miR-21 inhibitor combined with 5-FU in intestinal carcinoma and the molecular mechanisms. Methods Expression of miR-21 in intestinal carcinoma was analyzed by real-time PCR. Cell proliferation was deter- mined using CCK-8 kit. Expression of PTEN and phosphorylation of AKT was evaluated by Western blot. Results Expression of miR- 21 in intestinal carcinoma was higher than that in normal intestine. In contrast to 5-FU treatment alone, miR-21 inhibitor combined with 5-FU could suppress intestinal carcinoma cell lines HT-29 and LoVo more significantly in vitro ( P 〈 0. 001 ). Tumor suppressor gene FFEN was up-regulated while phosphorylation of AKT was down-regulated after combining treatment of miR-21 inhibitor and 5- FU, as showed with Western blot. Conclusion MiR-21 inhibitor can enhance the sensitivity of intestinal carcinoma cells to 5-FU.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2014年第2期131-134,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 江苏大学临床医学科技发展基金(JLY2010150)
关键词 肠肿瘤 miR-21抑制剂 5-氟尿嘧啶 intestinal neoplasms miR-21 inhibitor 5-FU
  • 相关文献

参考文献4

二级参考文献47

  • 1Chen C Z, Li L, Lodish H F, et al. MiRNA modulate hemato poietic lineage differentiation[J]. Science,2004, 303(5654): 83- 86.
  • 2Bartel D P. MiRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281- 297.
  • 3Blower P E, Chung J H, Verduai J S, et al. MiRNAs modulate the chemosensitivity of tumor cells[J]. Mol Cancer Ther, 2008, 7(1) :1-9.
  • 4Pascal S,Charles D. Chemoresistance in non small cell lung cancer[J]. Curr MedChem, 2005, 5(1):73-88.
  • 5Stewart D J. Mechanisms of resistance to cisplatin and carboplatin[J]. Crit RevOncol Hematol, 2007,63(1):12- 31.
  • 6H Zhu, H Wu, X P Liu, et al. Role of MiRNA miR 27a and miR-451 in the regulation of MDR1/P glycoprotein expression in human cancer cells[J]. Biochemical Pharmacology, 2008, 76 (5) : 582-588.
  • 7Xia L, Zhang D, Du R, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells[J]. Int J Cancer, 2008, 123(2): 372-379.
  • 8Kovalchuk O, Filkowski J, Meservv J, et al. Involvement of miR NA-451 in resistance of the MCF7 breast cancer ceils to chemothera peutic drug doxorubicin[J]. Mol Cancer Ther, 2008, 7 (7):2152- 2159.
  • 9Meng F, Henson R, Lang M, et al. Involvement of human mi RNA in growth and response to chemotherapy in human cholan giocarcinoma cell lines[J]. Gastroenterology, 2006, 130 (7):2113-2129.
  • 10Chan J A, Krichevsky A M, Kosik K S. MiRNA-21 is an anti apoptotic factor in human glioblastoma cells[J]. Cancer Res, 2005, 65(14):6029- 6033.

共引文献44

同被引文献43

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部